Prognostic method

Methods are provided for determining prognosis of multiple myeloma in a patient by measuring expression of BCMA in a sample. Also provided are methods for treating 5 multiple myeloma by measuring expression of BCMA in a sample and administering an effective amount of an antigen binding protein that...

Full description

Saved in:
Bibliographic Details
Main Authors McCahon, Lee, Seestaller-Wehr, Laura M, Yong, Kwee L, Craigen, Jenny L, Lee, Lydia, Paterson, Jennifer, Nevin (Nee Sully), Katherine, Fieles, William E, Germaschewski, Fiona M, Bounds, Danton, Mayes, Patrick A, Tunstead, James, Herledan, Gaelle, Rodriguez-Justo, Manuel
Format Patent
LanguageEnglish
Published 10.05.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods are provided for determining prognosis of multiple myeloma in a patient by measuring expression of BCMA in a sample. Also provided are methods for treating 5 multiple myeloma by measuring expression of BCMA in a sample and administering an effective amount of an antigen binding protein that binds BCMA. Also provided are kits for measuring BCMA expression in a sample.
Bibliography:Application Number: AU20160347516